Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 8486530, 8 pages
http://dx.doi.org/10.1155/2016/8486530
Research Article

Nanoformulation of Premixing Propofol Lipid Emulsion and Fentanyl Citrate and Their Effects on Acute Toxicity, Sedation, and Analgesia

1Department of Anesthesiology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
2Institute of Basic Medical Science, Xi’an Medical University, Xi’an 710021, China
3Electron Microscopy Room, Xi’an Jiaotong University Health Science Center, Xi’an 710061, China

Received 12 January 2016; Revised 18 March 2016; Accepted 20 March 2016

Academic Editor: Abdelwahab Omri

Copyright © 2016 Wei Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Baker and M. Naguib, “Propofol: The challenges of formulation,” Anesthesiology, vol. 103, no. 4, pp. 860–876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Jiang, Z.-B. Yang, Q.-H. Zhou, X. Huan, and L. Wang, “Lipid metabolism disturbances and AMPK activation in prolonged propofol-sedated rabbits under mechanical ventilation,” Acta Pharmacologica Sinica, vol. 33, no. 1, pp. 27–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. J. Theilen, S. Adam, M. D. Albrecht, and M. Ragaller, “Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects,” Anesthesia and Analgesia, vol. 95, no. 4, pp. 923–929, 2002. View at Google Scholar · View at Scopus
  4. I. Vasileiou, T. Xanthos, E. Koudouna et al., “Propofol: a review of its non-anaesthetic effects,” European Journal of Pharmacology, vol. 605, no. 1–3, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. O'Neil, The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, The Royal Society of Chemistry, 15th edition, 2013.
  6. S. D. Roy and G. L. Flynn, “Solubility and related physicochemical properties of narcotic analgesics,” Pharmaceutical Research, vol. 5, no. 9, pp. 580–586, 1988. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. A. Hendrickx, E. I. Eger, J. M. Sonner, and S. L. Shafer, “Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility,” Anesthesia and Analgesia, vol. 107, no. 2, pp. 494–506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Vuyk, “Pharmacokinetic and pharmacodynamic interactions between opioids and propofol,” Journal of Clinical Anesthesia, vol. 9, no. 6, supplement 1, pp. 23S–26S, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Kuipers, F. Boer, W. Olieman, A. G. L. Burm, and J. G. Bovill, “First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model,” Anesthesiology, vol. 91, no. 6, pp. 1780–1787, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A. Trissel, D. L. Gilbert, and J. F. Martinez, “Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration,” American Journal of Health-System Pharmacy, vol. 54, no. 11, pp. 1287–1292, 1997. View at Google Scholar · View at Scopus
  11. R. F. Grace, W. Tang, and E. Namel, “An audit of the haemodynamic and emergence characteristics of single-shot ‘ketofol’,” Anaesthesia and Intensive Care, vol. 43, no. 4, pp. 503–505, 2015. View at Google Scholar · View at Scopus
  12. B. Bachmann-Mennenga, A. Ohlmer, R. H. Boedeker, M. Mann, B. Mühlenbruch, and M. Heesen, “Preventing pain during injection of propofol: effects of a new emulsion with lidocaine addition,” European Journal of Anaesthesiology, vol. 24, no. 1, pp. 33–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. E. Healy and P. R. Knight, Wylie Churchill-Davidson's A Practice of Anesthesia, Taylor & Francis, 7th edition, 2003.
  14. Q. Zhao, M. Yang, Y. Deng et al., “The safety evaluation of salvianolic acid B and ginsenoside Rg1 combination on mice,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 29345–29356, 2015. View at Publisher · View at Google Scholar
  15. J. Buschmann, “The OECD guidelines for the testing of chemicals and pesticides,” Methods in Molecular Biology, vol. 947, pp. 37–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Rispin, D. Farrar, E. Margosches et al., “Alternative methods for the median lethal dose (LD50) test: the up-and-down procedure for acute oral toxicity,” ILAR Journal, vol. 43, no. 4, pp. 233–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhou, J. Yang, J. Liu, Y. Wang, and W. S. Zhang, “Efficacy comparison of the novel water-soluble propofol prodrug HX0969w and fospropofol in mice and rats,” British Journal of Anaesthesia, vol. 111, no. 5, pp. 825–832, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kashiwagi, Y. Okada, S.-I. Kuwana, S. Sakuraba, R. Ochiai, and J. Takeda, “Mechanism of propofol-induced central respiratory depression in neonatal rats: anatomical sites and receptor types of action,” Advances in Experimental Medicine and Biology, vol. 551, pp. 221–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Shintaku, T. Ohba, H. Niwa et al., “Effects of propofol on electrocardiogram measures in mice,” Journal of Pharmacological Sciences, vol. 126, no. 4, pp. 351–358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Whitehead, S. K. Schwarz, Y. I. Asiri, T. Fung, E. Puil, and B. A. MacLeod, “The efficacy and safety of the novel peripheral analgesic isovaline as an adjuvant to propofol for general anesthesia and conscious sedation: a proof-of-principle study in mice,” Anesthesia & Analgesia, vol. 121, no. 6, pp. 1481–1487, 2015. View at Publisher · View at Google Scholar
  21. S. Katayama, M. Irifune, N. Kikuchi et al., “Increased γ-aminobutyric acid levels in mouse brain induce loss of righting reflex, but not immobility, in response to noxious stimulation,” Anesthesia and Analgesia, vol. 104, no. 6, pp. 1422–1429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wu, N. Jia, C. Zhao et al., “Synergistic antinociception of propofol-alfentanil combination in mice,” Pharmacology Biochemistry and Behavior, vol. 116, pp. 25–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. H. Lichtman, “The up-and-down method substantially reduces the number of animals required to determine antinociceptive ED50 values,” Journal of Pharmacological and Toxicological Methods, vol. 40, no. 2, pp. 81–85, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Du, C. Wang, X. Tai, G. Wang, and X. Liu, “Optimization and characterization of biocompatible oil-in-water nanoemulsion for pesticide delivery,” ACS Sustainable Chemistry & Engineering, vol. 4, no. 3, pp. 983–991, 2016. View at Publisher · View at Google Scholar
  25. R. Nau, F. Sörgel, and H. Eiffert, “Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections,” Clinical Microbiology Reviews, vol. 23, no. 4, pp. 858–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Shi, W. Porter, T. Merdan, and L. C. Li, “Recent advances in intravenous delivery of poorly water-soluble compounds,” Expert Opinion on Drug Delivery, vol. 6, no. 12, pp. 1261–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. G. Stäuble, R. B. Stäuble, S. J. Schaller, C. Unterbuchner, H. Fink, and M. Blobner, “Effects of single-shot and steady-state propofol anaesthesia on rocuronium dose-response relationship: a randomised trial,” Acta Anaesthesiologica Scandinavica, vol. 59, no. 7, pp. 902–911, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L.-H. Tan and N.-C. Hwang, “The effect of mixing lidocaine with propofol on the dose of propofol required for induction of anesthesia,” Anesthesia & Analgesia, vol. 97, no. 2, pp. 461–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. F. Driscoll, H. N. Bhargava, L. Li, R. H. Zaim, V. K. Babayan, and B. R. Bistrian, “Physicochemical stability of total nutrient admixtures,” American Journal of Health-System Pharmacy, vol. 52, no. 6, pp. 623–634, 1995. View at Google Scholar · View at Scopus
  30. S. Kaya, S. Turhanoglu, H. Karaman, S. Özgün, and N. Basak, “Lidocaine for prevention of propofol injection-induced pain: a prospective, randomized, double-blind, controlled study of the effect of duration of venous occlusion with a tourniquet in adults,” Current Therapeutic Research—Clinical and Experimental, vol. 69, no. 1, pp. 29–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Masaki, M. Tanaka, and T. Nishikawa, “Physicochemical compatibility of Propofol-Lidocaine mixture,” Anesthesia and Analgesia, vol. 97, no. 6, pp. 1646–1651, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. W. Park, E.-S. Park, S.-C. Chi, H. Y. Kil, and K.-H. Lee, “The effect of lidocaine on the globule size distribution of propofol emulsions,” Anesthesia and Analgesia, vol. 97, no. 3, pp. 769–771, 2003. View at Google Scholar · View at Scopus
  33. D. F. Driscoll, J. Nehne, H. Peterss, R. Franke, B. R. Bistrian, and W. Niemann, “The influence of medium-chain triglycerides on the stability of all-in-one formulations,” International Journal of Pharmaceutics, vol. 240, no. 1-2, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Han, S. S. Davis, and C. Washington, “Physical properties and stability of two emulsion formulations of propofol,” International Journal of Pharmaceutics, vol. 215, no. 1-2, pp. 207–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. S. D. Roy and G. L. Flynn, “Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil,” Pharmaceutical Research, vol. 6, no. 2, pp. 147–151, 1989. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Kawakami, N. Oda, K. Miyoshi, T. Funaki, and Y. Ida, “Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents,” European Journal of Pharmaceutical Sciences, vol. 28, no. 1-2, pp. 7–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Berge, L. D. Bighley, and D. C. Monkhouse, “Pharmaceutical salts,” Journal of Pharmaceutical Sciences, vol. 66, no. 1, pp. 1–19, 1977. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Tsuji, “Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems,” NeuroRx, vol. 2, no. 1, pp. 54–62, 2005. View at Publisher · View at Google Scholar · View at Scopus